Scientists used IBM's R2 Heron quantum processor to predict the secondary protein structure of a 60-nucleotide-long mRNA ...

The surface of the SARS-CoV-2 virus is covered in protein spikes (red). Moderna’s messenger RNA (mRNA) vaccine would teach the human body to recognize these spikes, allowing the body to produce ...

If the Pfizer and Moderna vaccines successfully put an end to the COVID-19 pandemic, as they seem poised to do, we will owe our salvation to the development of mRNA vaccines — an unprecedented ...

The Department of Health and Human Services is canceling the development of 22 mRNA vaccines, citing a lack of efficacy for preventing respiratory viruses like the flu and COVID-19. The department ...

Moderna, a leader in mRNA medicine, developed one of the earliest COVID-19 vaccines, with Spikevax being its first commercial product. The company's mRNA platform enables the development of ...

Moderna -- a company formed specially to develop mRNA technology -- is working on personalized cancer vaccines. "We identify mutations found on a patient's cancer cells," the company says on its ...

Moderna and Coursera are offering the class for free to anyone who’s registered as a Coursera user. In doing so, the duo is “empowering learners worldwide to gain an in-depth understanding of ...

Pfizer's chief science officer said in an interview on Wednesday that the company chose a lower dose of mRNA in its COVID-19 vaccine than Moderna to minimize the risk of side effects.

Moderna’s mRNA vaccine reaches its final phase. Here's how it works. The biotech firm's leading candidate has just entered phase three clinical trials in the U.S. Find out why this vaccine ...